IDEXX Laboratories (IDXX) Revenue — Quarter Ended Mar 31, 2025
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential improvement reversed a prior-period decline, while the year-over-year growth continued at a moderated pace.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential improvement reversed a prior-period decline, while the year-over-year growth continued at a moderated pace.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$998.4M
Revenue reported for this quarter.
Quarter-over-quarter
+4.6%
Change from the immediately preceding quarter.
Year-over-year
+3.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $1B | +6.4% |
| Sep 30, 2024 | $975.5M | +6.6% |
| Dec 31, 2024 | $954.3M | +5.8% |
| Mar 31, 2025 | $998.4M | +3.6% |
Revenue performance
Reported revenue rose sequentially and year-over-year, marking a higher level following the prior quarter's decrease.
Quarterly comparison
Relative to the immediately preceding quarter, revenue increased, reversing the downward trend seen at the end of the prior fiscal year. Compared with the same quarter one year earlier, revenue also grew, though at a slower rate than in recent quarters.
What to watch
Revenue in the trailing twelve months remained above the level of the comparable prior period, but the pace of year-over-year growth has decelerated.